Clinical Trial Update: The Role of Adrenomedullin on the Outcome of Severe Heart Failure: a Clinical Randomized Study [NA]

View source ↗

Summary

A randomized clinical trial evaluating the role of adrenomedullin in outcome for severe heart failure was withdrawn from ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Adrenomedullin (adrenomedullin)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Heart Failure | NA | Status: WITHDRAWN